sec filing
AP
NASDAQ · APRE
Aprea Therapeutics, Inc.
Healthcare · Biotechnology
$0.73
Up+$0.02 (+2.67%)
Updated Sep 18, 2026, 1:00 AM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 6.41M
- P/E ratio
- -0.45
- Dividend yield
- 0.00%
- 52-week range
- $0.59 – $1.16
- Volume
- 186K
- Avg. volume
- 2.17M
Price performance
APRE price history
1M range · 19 trading sessions · Daily adjusted prices
APRE closed at $0.73 after 19 trading sessions, up 14.13% for the selected period.
- Last close
- $0.73
- Period change
- +14.13%
- Period low
- $0.64
- Period high
- $0.98
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $0.729 | $0.757 | $0.7111 | $0.7305 | 186K |
| Sep 15, 2026 | $0.82 | $0.82 | $0.7333 | $0.7488 | 184.18K |
| Sep 14, 2026 | $0.771 | $0.8427 | $0.76 | $0.7814 | 120.27K |
| Sep 11, 2026 | $0.7957 | $0.8199 | $0.7651 | $0.774 | 127.72K |
| Sep 10, 2026 | $0.7805 | $0.8101 | $0.7805 | $0.7892 | 61.33K |
| Sep 9, 2026 | $0.85 | $0.871 | $0.7832 | $0.7914 | 135.46K |
| Sep 8, 2026 | $0.8403 | $0.88 | $0.7788 | $0.835 | 323.72K |
| Sep 4, 2026 | $0.80 | $0.8092 | $0.7914 | $0.7943 | 90.48K |
| Sep 3, 2026 | $0.82 | $0.82 | $0.7802 | $0.8063 | 112.97K |
| Sep 2, 2026 | $0.8101 | $0.854 | $0.7986 | $0.82 | 170.56K |
| Sep 1, 2026 | $0.78 | $0.90 | $0.7795 | $0.8357 | 465.71K |
| Aug 31, 2026 | $0.8454 | $0.8517 | $0.78 | $0.80 | 479.83K |
| Aug 28, 2026 | $0.88 | $0.9099 | $0.8202 | $0.8386 | 346.18K |
| Aug 27, 2026 | $0.99 | $0.99 | $0.81 | $0.8601 | 1.18M |
| Aug 26, 2026 | $1.09 | $1.16 | $0.923 | $0.98 | 2.82M |
| Aug 25, 2026 | $0.815 | $0.99 | $0.8025 | $0.9499 | 2.15M |
| Aug 24, 2026 | $0.7042 | $0.85 | $0.6801 | $0.8052 | 2.8M |
| Aug 21, 2026 | $0.6565 | $0.6697 | $0.623 | $0.6403 | 14.85K |
| Aug 20, 2026 | $0.6721 | $0.6926 | $0.6328 | $0.6401 | 38.86K |
Latest APRE news
The latest Smart Investors Daily articles mentioning APRE.
Stock researchCompany · Dividend
Loading stock research…

